HilleVax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HilleVax and other ETFs, options, and stocks.

About HLVX

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. 

CEO
Robert M. Hershberg
CEORobert M. Hershberg
Employees
14
Employees14
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2020
Founded2020
Employees
14
Employees14

HLVX Key Statistics

Market cap
98.03M
Market cap98.03M
Price-Earnings ratio
-0.65
Price-Earnings ratio-0.65
Dividend yield
Dividend yield
Average volume
356.20K
Average volume356.20K
High today
$2.02
High today$2.02
Low today
$1.84
Low today$1.84
Open price
$1.92
Open price$1.92
Volume
416.97K
Volume416.97K
52 Week high
$16.31
52 Week high$16.31
52 Week low
$1.34
52 Week low$1.34

People also own

Based on the portfolios of people who own HLVX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.